In the news | 14th Apr 2023

How to speed up regulatory submission in drug development

Scott Weiss, Vice President, Business Development and Open Innovation, explores digital workflows with an “audit-by-exception” approach which helps speed up regulatory submission by reducing errors and time to compile data. This approach leads to greater transparency and better relationships with regulatory agencies and helps avoid delays to the market.

To learn more, read this article published in Drug Delivery & Development.

About IDBS Contact us

Svg+xml,%3Csvg%20xmlns%3D'http%3A%2F%2Fwww.w3

Putting Your CMC Ontology to Work | Pistoia Alliance 2026

14th October 2026 | 09:47

Join IDBS at the Pistoia Alliance conference as Ken Forman explores how organizations can transform a documented CMC ontology into a GxP-qualified operational framework. Learn how linking ontology to experimental data enables structured, submission-ready information, improving data exchange, regulatory compliance, and the efficiency of CMC processes.

CMC regulatory submissions: Why knowledge continuity matters

7th October 2026 | 18:06

Biopharma organizations have invested heavily in managing CMC data, yet many continue to face a less visible challenge: preserving the knowledge behind critical development decisions. As products progress through development and teams evolve, maintaining scientific context can become just as important as maintaining the underlying data.

i3 2027 registration

7th October 2026 | 11:57

IDBS i3 2027 brings together life sciences leaders to explore how connected data, AI, and modern informatics are transforming scientific innovation. Join us in Woking for 1.5 days of customer stories, expert insights, interactive sessions, and networking opportunities.

i3 Japan 2026

7th October 2026 | 06:00

Join us at i3 Japan and be part of the conversation shaping the future of BioPharma in Japan. Hear real-world case studies from IDBS users and gain insights from IDBS experts on our solutions.